Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib.

Myung Soo Kim Ho Seok Chung Eu Chang Hwang Seung Il Jung Dong Deuk Kwon Jun Eul Hwang Woo Kyun Bae Jae Young Park Chang Wook Jeong Cheol Kwak Cheryn Song Seong Il Seo Seok-Soo Byun Sung-Hoo Hong Jin-Soo Chung

Published in: Journal of Korean medical science (2018)

Our real-world data of Korean patients with mRCC suggested that SU and PZ had similar efficacies as first-line therapy for mRCC. However, PZ was better tolerated than SU in Korean patients.

Keyphrases

metastatic renal cell carcinoma
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
electronic health record
renal cell carcinoma
big data
patient reported outcomes
machine learning
patient reported